Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 46 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/99
End: -
Due: -
CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
Phase: N/A
Priority: Normal
Start: 07/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/92
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/95
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/02
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 06/30/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/89
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/03
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 06/30/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/03
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 07/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 03/31/08
Due: 03/31/09
Phase: N/A
Priority: Normal
Start: 12/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 04/30/11
Due: 04/30/12